Our experience with the use of the Interleukin-1 receptor antagonist in the treatment of the patient with CINCA/NOMID syndrome (case study - 5 years of therapy)

Our experience with the use of the Interleukin-1 receptor antagonist in the treatment of the patient with CINCA/NOMID syndrome (case study - 5 years of therapy)

Bibliographic Details
Main Authors:	Vargova V, Macejova Z
Format:	Article
Language:	English
Published:	BMC 2011-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

EXPERIENCE IN APPLICATION OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED SYNDROME (SYNDROME CINCA/NOMID)
by: T. V. Sleptsova, et al.
Published: (2014-05-01)

Experience with an IL-1ß inhibitor (anakinra) in a patient with CINCA/NOMID syndrome
by: S O Salugina, et al.
Published: (2012-09-01)

Cryopyrin-associated periodic syndromes (CAPS): report on two cases (Muckle-Wells syndrome (MWS) and CINCA/NOMID)
by: Kuzmina NN, et al.
Published: (2011-09-01)

Síndrome CINCA: um diagnóstico diferencial da artrite idiopática juvenil CINCA syndrome: a differential diagnosis of the juvenile idiopathic arthritis
by: Erica Naomi Naka, et al.
Published: (2007-08-01)

Entrevista a Víctor Lorenzo Cinca
by: Víctor Santiago de Dios Menéndez
Published: (2018-05-01)

Entrevista a Víctor Lorenzo Cinca
by: Víctor Santiago de Dios Menéndez
Published: (2018-05-01)

CINCA Syndrome With New NLRP3 Mutation and Unreported Complication of Thyroid Carcinoma
by: Farhad Salehzadeh, et al.
Published: (2019-06-01)

Nanorrelatos y microrrelatos, de Víctor Lorenzo Cinca
by: Víctor Lorenzo Cinca
Published: (2018-05-01)

Nanorrelatos y microrrelatos, de Víctor Lorenzo Cinca
by: Víctor Lorenzo Cinca
Published: (2018-05-01)

Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.
by: Pamela Aubert, et al.
Published: (2012-01-01)

Usefulness of interleukin 1 receptor antagonist (anakinra) in refractory post-pericardiotomy syndrome
by: Marta Flores Fernández, et al.
Published: (2021-09-01)

Interleukin expression after injury and the effects of interleukin-1 receptor antagonist.
by: Connie S Chamberlain, et al.
Published: (2013-01-01)

12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment
by: Paloni G, et al.
Published: (2008-09-01)

Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression
by: Yu-Ching Fan, et al.
Published: (2020-12-01)

Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes.
by: Elena Vecile, et al.
Published: (2013-01-01)

Woronoff Ring in Deficiency of Interleukin-36 Receptor Antagonist (DITRA)
by: Daniel Morgado-Carasco, et al.
Published: (2019-12-01)

Role of interleukin-25 in development of spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice
by: Yasuharu Abe, et al.
Published: (2017-12-01)

Analysis of Anakinra Therapy for the Deficiency of Interleukin-1 Receptor Antagonist through Clinical Evidence
by: Kathryn Pillai, et al.
Published: (2024-02-01)

Martínez-Pujalte, Antonio-Luis. Derechos fundamentales y discapacidad. Madrid: CINCA, 2015.
by: Vicente Bellver Capella
Published: (2017-06-01)

The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis
by: L. Riente
Published: (2011-09-01)

Interleukin-6 receptor antagonists in critically ill patients with Covid-19
by: Gordon, AC, et al.
Published: (2021)

Interleukin-17 receptor antagonist reduces inflammatory response in experimental periodontitis
by: Dr Takenori Sato, et al.
Published: (2023-09-01)

Mitoprotective effect of the receptor antagonist interleukin-1 in experimental cerebral stroke
by: E. V. Suprun
Published: (2012-12-01)

Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium.
by: Hung, G, et al.
Published: (1994)

Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13
by: Corrado Pelaia, et al.
Published: (2022-06-01)

Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.
by: Deleuran, B, et al.
Published: (1992)

Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
by: Queenie Hui, et al.
Published: (2017-08-01)

Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta.
by: Turner, M, et al.
Published: (1991)

INTRAARTICULAR EXPRESSION OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN BY EXVIVO GENE-TRANSFER
by: Bandara, G, et al.
Published: (1993)

The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion
by: Lisa Schneider, et al.
Published: (2021-05-01)

A peptoid interleukin‐15 receptor antagonist suppresses inflammation and arthritis in mice
by: Kwang Bog Cho, et al.
Published: (2022-01-01)

Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion
by: Liu Mengyuan, et al.
Published: (2012-09-01)

Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension
by: Christine B. Bui, et al.
Published: (2019-07-01)

The Clinical Significance of Interleukin-1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis.
by: Endom Ismail, et al.
Published: (2016-01-01)

Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome
by: Pierre Quartier
Published: (2011-01-01)

Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome
by: Valentina Parisi, et al.
Published: (2020-02-01)

Content of C-reactive protein, interleukin-1, interleukin-6 and interleukin-1 receptor antagonist in the blood of patients with early osteoarthrosis of the knee joints
by: M S Svetlova, et al.
Published: (2009-06-01)

Hysteroscopic Outcomes in Our Clinic: 5 Years Experience
by: Osman Balcı, et al.
Published: (2007-12-01)

Spinal Cord Tumors—Our 5-Year Experience
by: Manpreet S. Banga, et al.
Published: (2022-01-01)

Impact of the Functional VNTR Variants of the Interleukin-1 Receptor Antagonist and Interleukin-4 Genes on Oral Squamous Cell Carcinoma
by: Özge Gümüşay, et al.
Published: (2019-05-01)